Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE Study for HCV Treatment in People Who Inject Drugs
NCT03236506Phase 2Completed
- Sponsor
- University of Dundee
- Start
- Jan 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of grazoprevir, sofosbuvir in hepatitis C (HCV), sponsored by University of Dundee. Started Jan 2018; status: completed.
02
Drugs
grazoprevirsofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03236506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236506.